Skip to main content

and
  1. Article

    Open Access

    Exploring the impact of the reclassification of a hereditary cancer syndrome gene variant: emerging themes from a qualitative study

    The complexity of genetic variant interpretation means that a proportion of individuals who undergo genetic testing for a hereditary cancer syndrome will have their test result reclassified over time. Such a r...

    Laura Wedd, Margaret Gleeson, Bettina Meiser, Rosie O’Shea in Journal of Community Genetics (2023)

  2. Article

    Open Access

    A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome

    Routine screening of tumors for DNA mismatch repair (MMR) deficiency (dMMR) in colorectal (CRC), endometrial (EC) and sebaceous skin (SST) tumors leads to a significant proportion of unresolved cases classifie...

    Romy Walker, Khalid Mahmood, Jihoon E. Joo in Journal of Translational Medicine (2023)

  3. Article

    Open Access

    Correction: When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans

    Michelle Wong-Brown, Mary McPhillips in Hereditary Cancer in Clinical Practice (2022)

  4. Article

    Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients

    The increasing use of genetic testing for BRCA1/2 and other pathogenic variants in the management of women with breast and ovarian cancer necessitates increased genetic literacy in oncology healthcare professiona...

    Bettina Meiser, Paula Woodward, Margaret Gleeson, Maira Kentwell in Familial Cancer (2022)

  5. No Access

    Article

    NTHL1-associate polyposis: first Australian case report

    While familial adenomatous polyposis accounts for approximately 1% of all colorectal cancer, the genetic cause underlying the development of multiple colonic adenomas remains unsolved in many patients. Adenoma...

    Alexandra Groves, Margaret Gleeson, Allan D. Spigelman in Familial Cancer (2019)

  6. Article

    Open Access

    When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans

    Since the identification of BRCA1 there has only ever been described two bi-allelic mutation carriers, one of whom was subsequently shown to be a mono-allelic carrier. The second patient diagnosed with two BRCA1 ...

    Michelle Wong-Brown, Mary McPhillips in Hereditary Cancer in Clinical Practice (2016)

  7. Article

    Open Access

    The curious case of a woman with two BRCA1 mutations in trans

    Rodney J Scott, Michelle Wong-Brown in Hereditary Cancer in Clinical Practice (2015)

  8. No Access

    Article

    Health professionals’ evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer

    Increasingly, women are offered genetic testing shortly after diagnosis of breast cancer to facilitate decision-making about treatment, often referred to as ‘treatment-focused genetic testing’ (TFGT). As under...

    Kirsten F. L. Douma, Bettina Meiser, Judy Kirk, Gillian Mitchell in Familial Cancer (2015)

  9. No Access

    Article

    ‘It’s the nature of the subject’: Secondary teachers’ disciplinary beliefs and decisions about teaching academic language in their content classes

    The national curriculum (Ministry of Education, 2007) requires secondary school teachers in New Zealand to promote academic language learning in their content areas. However, it is unclear how subject teachers...

    Margaret Gleeson in The Australian Journal of Language and Literacy (2015)

  10. Article

    Open Access

    How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer

    Germline BRCA1 and BRCA2 mutation testing offered shortly after a breast cancer diagnosis to inform women’s treatment choices - treatment-focused genetic testing ‘TFGT’ - has entered clinical practice in speciali...

    Kaaren J Watts, Bettina Meiser, Gillian Mitchell, Judy Kirk in BMC Cancer (2012)

  11. No Access

    Chapter

    The Meaning of Vital Signs

    The four classic vital signs are respiratory rate, temperature, pulse rate and blood pressure. Although their measurement has been standard practice for over a century, there have been few attempts to quantify...

    John Kellett, Breda Deane, Margaret Gleeson in Textbook of Rapid Response Systems (2011)